-+ 0.00%
-+ 0.00%
-+ 0.00%

ASCLETIS ANNOUNCES INITIATION OF PHASE I STUDY IN U.S. FOR ORAL AMYLIN RECEPTOR PEPTIDE AGONIST ASC36 FOR THE TREATMENT OF OBESITY

路透·09/08/2026 10:10:00

登录查看新闻详情